ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,346.99
-0.11%
Dow Jones
38,798.99
-0.22%
US Dollar vs MXN
18.4136
0.00%
Brent Oil
79.395
0.00%
Bitcoin
69,400.08
0.10%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Avadel Pharmaceuticals PLC (AVDL)

  7. Avadel Pharmaceuticals PLC (AVDL) Noticias

AVDL Avadel Pharmaceuticals PLC

15.13
-0.12 (-0.79%)
07 Jun 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Avadel Pharmaceuticals PLC AVDL NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.12 -0.79% 15.13 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
15.20 14.95 15.60 15.13 15.25
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
30/5/202407:00GLOBEAvadel Pharmaceuticals to Present at Upcoming Investor..
22/5/202407:00GLOBEAvadel Pharmaceuticals Shares New LUMRYZ™ (sodium oxybate)..
21/5/202416:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/5/202416:27EDGAR2Form 3 - Initial statement of beneficial ownership of..
21/5/202406:04EDGAR2Form 8-K - Current report
21/5/202406:00GLOBEAvadel Pharmaceuticals Appoints Naseem Amin, M.D. to its..
17/5/202415:18EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/5/202415:17EDGAR2Form 8-K - Current report
08/5/202415:06EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
08/5/202408:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202407:29IHMARKETNEWSU.S. Futures Slightly Dip Amid Corporate Earnings and Quiet..
08/5/202406:08EDGAR2Form 8-K - Current report
08/5/202406:00GLOBEAvadel Pharmaceuticals Provides Corporate Update and Reports..
01/5/202407:00GLOBEAvadel Pharmaceuticals to Provide a Corporate Update and..
01/4/202407:00GLOBEAvadel Pharmaceuticals to Present at the 23rd Annual Needham..
05/3/202407:00GLOBEAvadel Pharmaceuticals to Present at Upcoming Investor..
04/3/202414:51EDGAR2Form 8-K - Current report
04/3/202414:37GLOBEAvadel Pharmaceuticals Issues Statement On Patent Litigation
04/3/202405:35EDGAR2Form 8-K - Current report
04/3/202405:30GLOBEAvadel Pharmaceuticals Provides Corporate Update and Reports..
04/3/202405:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202405:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202405:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202407:00GLOBEAvadel Pharmaceuticals to Provide a Corporate Update and..
14/2/202406:11EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202416:54EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202415:39EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202408:40EDGAR2Form SC 13G - Statement of acquisition of beneficial..
12/2/202407:20EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/2/202407:00GLOBEAvadel Pharmaceuticals to Present at the Oppenheimer 34th..
16/1/202415:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202406:20EDGAR2Form 8-K - Current report
08/1/202406:00GLOBEAvadel Pharmaceuticals Announces Strong LUMRYZ Launch..
29/12/202315:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/12/202313:54EDGAR2Form 144 - Report of proposed sale of securities
08/11/202308:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202306:09EDGAR2Form 8-K - Current report
08/11/202306:00GLOBEAvadel Pharmaceuticals Provides Corporate Update and Reports..
07/11/202307:00GLOBEAvadel Pharmaceuticals to Present at Upcoming Investor..
30/10/202307:00GLOBEAvadel Pharmaceuticals to Provide a Corporate Update and..
20/10/202307:00GLOBEAvadel Pharmaceuticals Announces Data Supporting Clinical..
05/10/202307:00GLOBEAvadel Pharmaceuticals to Present at the Jefferies Biotech..
01/9/202320:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/9/202320:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/8/202307:00GLOBEAvadel Pharmaceuticals to Present at Upcoming Investor..
15/8/202315:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202316:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202315:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202314:50EDGAR2Form 144 - Report of proposed sale of securities
10/8/202317:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Su Consulta Reciente

NASDAQ
AVDL
Avadel Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados